title: High dose pancreatic enzymes in cystic fibrosis.
abstract: Seven patients with cystic fibrosis taking high doses of pancreatin supplements were assessed to determine whether this dose was necessary to achieve adequate fat absorption. Patients reduced their intake from a group mean of 45 to 21 capsules a day. Five patients did not have any significant alteration in fat malabsorption while taking the reduced enzyme dose.
authors.affiliation: Department of Thoracic Medicine, Royal Children's Hospital, Melbourne, Australia.
authors.forename: P J
authors.initials: PJ
authors.lastname: Robinson
authors.forename: P D
authors.initials: PD
authors.lastname: Sly
mesh_terms: D000293:Adolescent; D002648:Child; D003550:Cystic Fibrosis / Q000378:metabolism / Q000628:therapy*; D004041:Dietary Fats / Q000378:metabolism; D005260:Female; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D008297:Male; D010194:Pancreatin / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D004041:Dietary Fats; D010194:Pancreatin